Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.99M P/E - EPS this Y - Ern Qtrly Grth -
Income -31.01M Forward P/E -0.74 EPS next Y - 50D Avg Chg -36.00%
Sales 661.98k PEG - EPS past 5Y - 200D Avg Chg -64.00%
Dividend N/A Price/Book 0.26 EPS next 5Y - 52W High Chg -87.00%
Recommedations 1.70 Quick Ratio 3.50 Shares Outstanding 13.25M 52W Low Chg 1.00%
Insider Own 55.91% ROA -35.13% Shares Float 1.35B Beta -0.12
Inst Own 27.05% ROE -80.80% Shares Shorted/Prior 120.38K/333.37K Price 1.47
Gross Margin - Profit Margin - Avg. Volume 9,882 Target Price 6.00
Oper. Margin -9,466.24% Earnings Date Sep 30 Volume 29,203 Change -13.02%
About Bionomics Limited - American De

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. The company has a collaboration with Merck & Co., Inc. to identify novel a7 Nicotinic Acetylcholine Receptor PAMs suitable for the treatment of cognitive disorder. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

Bionomics Limited - American De News
11/08/24 Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement
11/07/24 Bionomics to Present at the 2024 CNS Summit
11/04/24 Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program
05:00 AM Bionomics to Present at the ThinkEquity Conference
10/14/24 Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
10/08/24 Bionomics CEO believes company has ‘significant, unrealized value’
10/07/24 Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision
10/01/24 Bionomics Limited announces intention to re-domicile to the United States
09/03/24 Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
07/31/24 Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder
07/29/24 Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024
07/18/24 Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder
05/31/24 Bionomics Limited Announces Private Placement of up to $70.0 Million
05/20/24 Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
03/21/24 Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder
03/20/24 Bionomics First Half 2024 Earnings: AU$1.62 loss per share (vs AU$2.16 loss in 1H 2023)
02/22/24 Bionomics to Present at the 2024 BIO CEO & Investor Conference
02/05/24 10 Best Australian Stocks To Buy
02/04/24 7 Strong Buy Stocks Under $20: February 2024
01/22/24 Bionomics Provides a Review of 2023 and of 2024 Plans
BNOX Chatroom

User Image scroogey8 Posted - 9 hours ago

$BNOX GREAT 👍 GOOD LUCK

User Image Swift_Trades Posted - 13 hours ago

$BNOX 🤫

User Image frontiere Posted - 16 hours ago

$BNOX Bionomics NEUP Neuphoria — long — terminates agreement w Cantor and signs $2m ATM w HCW. Interesting, why. Cantor seems to have worked fine for them given the vicious spikes although the ave selling price maybe could have been higher (they achieved effective ~$4.00 price per ATM share in Aug-Sep, despite the $9+ highs). Will be instructive to see changes in future stock behavior, if any. 🧐 https://www.sec.gov/ix?doc=/Archives/edgar/data/1191070/000121390024100971/ea0221911-8k_bionom.htm

User Image lecorb Posted - 18 hours ago

$BNOX Nov 21, 2024 4:01 PMCurrent report pursuant to Section 13 or 15(d) - Form 8-K https://app.quotemedia.com/data/downloadFiling?type=HTML&webmasterId=500&ref=318738019

User Image NewMike Posted - 1 day ago

$APDN should move like $BNOX and $PRFX soon

User Image Goldpay55 Posted - 1 day ago

$BNOX maybe manage could give us an update on ongoing trials or merger/acquisition talks?

User Image Swift_Trades Posted - 2 days ago

$BNOX 🔨🛢️

User Image SirButtCheeks Posted - 2 days ago

$BNOX 270k sell on ask hmm

User Image Swift_Trades Posted - 2 days ago

$BNOX woahhh

User Image taki Posted - 3 days ago

$BNOX special event? Huh?

User Image Soldad0Blanc0 Posted - 3 days ago

$BNOX get more that’s all I’m telling yall.

User Image Emiclea Posted - 3 days ago

$BNOX undervalued after the filling this is a bargain

User Image Swift_Trades Posted - 3 days ago

$BNOX 👋👋👋🛍️🛒🛍️🛒

User Image Swift_Trades Posted - 3 days ago

$BNOX it's gearing up for a new 52 week high

User Image occidental Posted - 3 days ago

$BNOX Looking strong volume upticking

User Image Swift_Trades Posted - 3 days ago

$BNOX 🔊🆙

User Image scroogey8 Posted - 3 days ago

$BNOX LOOKING GOOD 👍

User Image Swift_Trades Posted - 3 days ago

$BNOX $1 🎯

User Image Swift_Trades Posted - 3 days ago

$BNOX LET'S GO! 🚀🔥

User Image Swift_Trades Posted - 3 days ago

$BNOX ✊💎

User Image Goldpay55 Posted - 3 days ago

$BNOX I'm holding thru the issuance of the new stock. I expect it to shoot up to the equiv. of $3 or more in issue date. The stock target price is $7 to $10. This will be the great price reset. IMO

User Image frontiere Posted - 3 days ago

@occidental yeah I mean you are correct but I wouldn’t put the cart before the horse — SAD reads out sooner and is within their existing $$ budget. And the SAD results will be indicative of PTSD prospects. While the announcement of PTSD Ph3 initiation now might produce a pop in stock price, I wouldn’t bet on it. The well-informed trader knows they need additional $$ funding to run and complete PTSD . Biochemically / scientifically, their tablet reformulation improved its profile. Good odds of a +ve readout in SAD. Read 10-K for details (or I had posted relevant excerpts in the inaugural thread a year ago). $BNOX

User Image frontiere Posted - 3 days ago

$BNOX Bionomics NEUP — fyi total float now 19.5m ADS up from 17.3m as of 2024-09-30. (19.4m ➔ 1.67million NEUP post end December 12:1 r/s , if approved). From S-3: …As of November 18, 2024, the aggregate market value of our ADSs held by non-affiliates, or public float, was approximately $12,621,277 based on 19,417,351 ADSs outstanding (representing 3,495,123,216 ordinary shares) outstanding… Full S-3 worth reading carefully, as always https://www.sec.gov/Archives/edgar/data/1191070/000121390024099678/ea0221564-s3_bionomics.htm

User Image Jon752 Posted - 3 days ago

$BNOX I just received my proxy from Schwab for the upcoming vote. I have 12,000 ADS with Schwab and the proxy was for 1,000 shares. I realize this is what I will own assuming the vote passes, but is this the correct way to handle this?

User Image ka1954 Posted - 3 days ago

$BNOX most people don't realize that companies have to put out these type of sec filings because if stop pops and they don't have this sec filing, they can't dilute. so Yes, this means this will be dilution but most likely after a big pop.

User Image Solosmomma Posted - 4 days ago

$BNOX please read the filing of the offering carefully. It’s a filing for them to offer up to 100 million shares from time to time. Likely during a catalyst with an uptick in volume. Not unexpected and not before the transition to the US markets. If this transition causes an increase in volume likely there will be an offering. I’m loaded up with cheap shares while ya all panic

User Image Goldpay55 Posted - 4 days ago

$BNOX headed to .18 ?

User Image DonCorleone77 Posted - 4 days ago

$BNOX Bionomics files $100M mixed securities shelf

User Image Bandit86 Posted - 4 days ago

$BNOX every pump and dump leaves a lot of bagholders for me to laugh at, thanks for the $4k

User Image Goldpay55 Posted - 4 days ago

$BNOX not going anywhere until the company has something to

Analyst Ratings
HC Wainwright & Co. Buy Aug 1, 24
HC Wainwright & Co. Buy Jul 18, 24
HC Wainwright & Co. Buy Jun 12, 24
HC Wainwright & Co. Buy Mar 21, 24
HC Wainwright & Co. Buy Dec 7, 23
Maxim Group Buy Sep 28, 23
HC Wainwright & Co. Buy Sep 28, 23
Maxim Group Buy Jun 16, 23
Evercore ISI Group Outperform Mar 10, 23